| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Director
1 company
Heier Jeffrey S. is a Chief Scientific Officer at Ocular Therapeutix, Inc.. Recent SEC Form 4 filings include 2 buys and 7 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Scientific Officer | Sell | 3,057 | $8.28 | $25,311.96 | -0.9% | -2.3% | - | |
| Nov 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 3,469 | $12.04 | $41,766.76 | -1.4% | -30.4% | - | |
| Oct 2, 2025 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 10,502 | $11.04 | $115,942.08 | -4.0% | +9.8% | - | |
| Aug 25, 2025 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 3,063 | $12.04 | $36,878.52 | -1.2% | +1.9% | - | |
| May 23, 2025 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 3,024 | $7.18 | $21,712.32 | -1.1% | +66.2% | +12.7% | |
| Feb 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 3,061 | $6.87 | $21,029.07 | -1.1% | +3.3% | +33.3% | |
| Nov 25, 2024 | OCUL Ocular Therapeutix, Inc | Chief Scientific Officer | Sell | 2,948 | $9.01 | $26,561.48 | -1.1% | -26.1% | +33.4% | |
| May 12, 2022 | OCUL Ocular Therapeutix, Inc | Director | Buy | 15,000 | $3.05 | $45,750.00 | +62.5% | +93.0% | +106.3% | |
| Mar 15, 2019 | OCUL Ocular Therapeutix, Inc | Director | Buy | 24,000 | $4.15 | $99,600.00 | New | - | - |